Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.
HRQoL
Psychometric properties
Quality of life
Sarcopenia
Validation
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
11
04
2023
accepted:
08
05
2023
medline:
24
7
2023
pubmed:
23
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
Patient perspectives are now widely recognized as a key element in the evaluation of health interventions. Therefore, the provision of specific and validated Patient Reported Outcome Measures that emphasize the lived experience of patients suffering from specific diseases is very important. In the field of sarcopenia, the only validated specific health-related quality of life (HRQoL) instrument available is the Sarcopenia Quality of Life questionnaire (SarQoL). This self-administrated HRQoL questionnaire, developed in 2015, consists of 55 items arranged into 22 questions and has currently been translated into 35 languages. Nineteen validation studies performed on SarQoL have consensually confirmed the capacity of SarQoL to detect difference in HRQoL between older people with and without sarcopenia, its reliability and its validity. Two further observational studies have also indicated its responsiveness to change. A short form SarQoL, including only 14 items has further been developed and validated to reduce the potential burden of administration. Research on the psychometric properties of SarQoL questionnaire is still encouraged as the responsiveness to change of SarQoL has not yet been measured in the context of interventional studies, as limited prospective data currently exist and as there is still not cut-off score to define a low HRQoL. In addition, SarQoL has mainly been used in community-dwelling older individuals with sarcopenia and would benefit to be studied in other types of populations. This review aims to provide to researchers, clinicians, regulators, pharmaceutical industries and other stakeholders a clear summary of comprehensive evidence on the SarQoL questionnaire published up to January 2023Query.
Identifiants
pubmed: 37219755
doi: 10.1007/s40520-023-02438-3
pii: 10.1007/s40520-023-02438-3
pmc: PMC10363087
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1581-1593Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2023. The Author(s).
Références
Clin Nutr. 2019 Feb;38(1):159-164
pubmed: 29395372
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Calcif Tissue Int. 2021 Oct;109(4):415-422
pubmed: 33991208
Arch Gerontol Geriatr. 2023 Jan;104:104799
pubmed: 36070636
BMC Musculoskelet Disord. 2022 Mar 1;23(1):191
pubmed: 35232420
Aging Clin Exp Res. 2021 Nov;33(11):2979-2988
pubmed: 33538991
J Formos Med Assoc. 2023 Mar;122(3):249-257
pubmed: 36198517
J Clin Epidemiol. 2003 Jan;56(1):52-60
pubmed: 12589870
Calcif Tissue Int. 2020 Mar;106(3):274-282
pubmed: 31781790
Age Ageing. 2017 Mar 1;46(2):271-276
pubmed: 27789428
JAMA Netw Open. 2020 Oct 1;3(10):e2020836
pubmed: 33074327
Qual Life Res. 2021 Aug;30(8):2349-2362
pubmed: 33782793
Eur Geriatr Med. 2019 Dec;10(6):853-862
pubmed: 34652767
Qual Life Res. 1993 Aug;2(4):287-95
pubmed: 8220363
Aging Clin Exp Res. 2018 Apr;30(4):307-313
pubmed: 29197020
Age Ageing. 2015 Nov;44(6):960-6
pubmed: 26433796
Age Ageing. 2019 Mar 1;48(2):220-228
pubmed: 30462162
Ann Geriatr Med Res. 2020 Jun;24(2):139-147
pubmed: 32743334
J Am Med Dir Assoc. 2021 Apr;22(4):809-815
pubmed: 33067129
PLoS One. 2019 Apr 29;14(4):e0216065
pubmed: 31034498
Eur Geriatr Med. 2019 Oct;10(5):761-767
pubmed: 34652695
BMC Geriatr. 2022 Apr 27;22(1):368
pubmed: 35477354
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1228-1243
pubmed: 37139947
J Clin Densitom. 2012 Jan-Mar;15(1):32-8
pubmed: 22071030
Int J Integr Care. 2002;2:e15
pubmed: 16896390
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):512-514
pubmed: 27891296
Korean J Fam Med. 2013 Jul;34(4):281-8
pubmed: 23904958
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Disabil Rehabil. 2020 Apr;42(7):1006-1012
pubmed: 30453790
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):238-244
pubmed: 27897430
Adv Ther. 2018 Nov;35(11):1842-1858
pubmed: 30374809
J Clin Med. 2018 Nov 26;7(12):
pubmed: 30486262
Aging Clin Exp Res. 2023 Jan;35(1):137-145
pubmed: 36289155
J Patient Rep Outcomes. 2022 Apr 20;6(1):38
pubmed: 35441987
J Frailty Aging. 2021;10(2):193-194
pubmed: 33575714
Aging Clin Exp Res. 2020 Aug;32(8):1501-1514
pubmed: 32162241
Aging Clin Exp Res. 2022 Mar;34(3):505-514
pubmed: 34398438
Arch Osteoporos. 2017 Nov 14;12(1):103
pubmed: 29139012
Rev Bras Fisioter. 2012 Sep-Oct;16(5):360-7
pubmed: 22983215
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Sao Paulo Med J. 2023 Jan-Feb;141(1):30-35
pubmed: 36043677
Qual Life Res. 2021 Feb;30(2):603-611
pubmed: 32914375
PLoS One. 2017 Jan 17;12(1):e0169548
pubmed: 28095426
J Nutr Health Aging. 2012;16(9):769-74
pubmed: 23131819
Patient Relat Outcome Meas. 2018 Nov 01;9:353-367
pubmed: 30464666
J Musculoskelet Neuronal Interact. 2018 Dec 1;18(4):463-472
pubmed: 30511950
Int J Environ Res Public Health. 2022 Apr 10;19(8):
pubmed: 35457429
J Frailty Aging. 2022;11(3):267-273
pubmed: 35799431
J Am Med Dir Assoc. 2011 Mar;12(3):226-33
pubmed: 21333926
Aging Clin Exp Res. 2019 Jan;31(1):5-14
pubmed: 29549649
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
J Clin Med. 2018 Oct 04;7(10):
pubmed: 30287728